Organization
Fundación GECP
16 clinical trials
Clinical trial
A Phase II Open Label Study of Atezolizumab in Combination With Bevacizumab as First Line Treatment for Locally Advanced or Metastasic High-intermediate Tumor Mutation Burden Selected Non-squamous Non-small Cell Lung Cancer Patients.Status: Active (not recruiting), Estimated PCD: 2024-11-30
Clinical trial
A Phase III Clinical Trial of Adjuvant Chemotherapy vs Chemoimmunotherapy for Stage IB-IIIA Completely Resected Non-small Cell Lung Cancer (NSCLC) Patients.Status: Active (not recruiting), Estimated PCD: 2030-04-01
Clinical trial
Characteristics of Sexual Dysfunction in Patients With Lung CancerStatus: Completed, Estimated PCD: 2024-02-29
Clinical trial
A Phase II Single Arm Clinical Trial Assessing the Efficacy and Safety of BIntrafusp Alfa (M7824) in Previously Treated Advanced Malignant Pleural MESothelioma (BIMES)Status: Recruiting, Estimated PCD: 2025-03-30
Clinical trial
Phase II Clinical Trial of AMG510 (Sotorasib) in Stage III Unresectable NSCLC KRAS p.G12C Patients and Medically Ineligible for Concurrent Chemo-radiotherapyStatus: Recruiting, Estimated PCD: 2027-12-31
Clinical trial
A Randomized Phase II Study of Neo-adjuvant Chemo/Immunotherapy Versus Chemotherapy Alone for the Treatment of Locally Advanced and Potentially Resectable Non-small Cell Lung Cancer (NSCLC) Patients.Status: Active (not recruiting), Estimated PCD: 2027-11-30
Clinical trial
Clinical Utility of Liquid Biopsy as a Tool to Assess the Evolution of Brigatinib Treated Patients With Non-small Cell Lung Cancer With EML4-ALK Translocation: an Exploratory StudyStatus: Active (not recruiting), Estimated PCD: 2024-12-30
Clinical trial
Phase II Clinical Trial of Neo-adjuvant Chemo/Immunotherapy Followed by Adjuvant Treatment Depending on the Resection Status for the Treatment of NSCLC Patients Diagnosed With Pancoast Tumor. A Multicenter Exploratory StudyStatus: Recruiting, Estimated PCD: 2028-03-01
Clinical trial
A Phase II Trial of Neoadjuvant Treatment Carboplatin-Pemetrexed-Bevacizumab Plus Atezolizumab for the Treatment of Locally Advanced and Potentially Resectable NSCLC Patients With EGFR MutationsStatus: Recruiting, Estimated PCD: 2024-12-30
Clinical trial
A Phase III Clinical Trial of Adjuvant Treatment With Sacituzumab and Zimberelimab for Stage IB-IIIA-IIIB(N2) Previously Resected (R0) Non-small Cell Lung Cancer Patients That Did Not Achieve Pathological Complete Response After Neoadjuvant treatment_ARIANStatus: Not yet recruiting, Estimated PCD: 2031-06-15
Clinical trial
A Phase II Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer (ES-SCLC)Status: Recruiting, Estimated PCD: 2026-07-30
Clinical trial
Nivolumab Plus Ipilimumab Plus Two Cycles of Platinum-based Chemotherapy as First Line Treatment for Stage IV/Recurrent Non-small Cell Lung Cancer (NSCLC) Patients With Synchronous Brain MetastasesStatus: Recruiting, Estimated PCD: 2026-03-15
Clinical trial
Retrospective Observational Study of Resectable Stage IIIA Non-small Cell Lung Cancer Patients: Pathological Response After Neoadjuvant Treatment and Patient OutcomesStatus: Recruiting, Estimated PCD: 2024-03-30
Clinical trial
Retrospective, Observational Study On The Efficacy And Safety Of Lorlatinib In ALK or ROS1 Metastatic Non-Small Cell Lung Cancer Patients Treated Within The Compassionate Use Program In SpainStatus: Completed, Estimated PCD: 2022-12-30
Clinical trial
A Phase II Trial of Atezolizumab Plus Induction Chemotherapy (CT) Plus Chemo-radiotherapy and Atezolizumab Maintenance Therapy in Non-resectable Stage IIIA-IIIB Non-small Cell Lung Cancer (NSCLC) PatientsStatus: Recruiting, Estimated PCD: 2026-11-15
Clinical trial
Phase II Clinical Trial of AMG510 (Sotorasib) in Stage III Unresectable NSCLC KRAS p.G12C Patients and Medically Ineligible for Concurrent Chemo-radiotherapyStatus: Recruiting, Estimated PCD: 2027-12-31